Literature DB >> 10913499

Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease.

J L Isaacsohn1, M H Davidson, D Hunninghake, R Singer, R McLain, D M Black.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10913499     DOI： 10.1016/s0002-9149(00)00872-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  3 in total

Review 1.  New and emerging data from clinical trials of statins.

Authors:  John C LaRosa
Journal:  Curr Atheroscler Rep       Date:  2004-01       Impact factor: 5.113

Review 2.  Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.

Authors:  H S Malhotra; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Results of new statin trials: should the low-density lipoprotein cholesterol treatment guidelines be revised?

Authors:  Allison M J Ross; Theodore G Ganiats
Journal:  Curr Atheroscler Rep       Date:  2005-02       Impact factor: 5.113
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.